Skip to content

Feasibility Study of Balloon Eustachian Tuboplasty (BET)

Feasibility Study of Balloon Eustachian Tuboplasty (BET) for Grade 2 and 3 Pars Tensa Retractions

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02631187
Acronym
BET
Enrollment
0
Registered
2015-12-16
Start date
2016-03-31
Completion date
2017-03-31
Last updated
2017-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eustachian Tube Dysfunction, Retraction of the Pars Tensa of the Tympanic Membrane, Retraction Pocket of the Tympanic Membrane

Keywords

Grade 2 retraction of the pars tensa of the tympanic membrane, Grade 3 retraction of the pars tensa of the tympanic membrane

Brief summary

This is a study that aims to evaluate the feasibility of undertaking a United Kingdom (UK) multi-centre randomised controlled trial of BET for the treatment of moderate (grade 2 or 3) retraction pockets (RPs). This future study will aim to address the question: Does BET improve symptoms scores, audiometry and otoscopic appearance of Grade 2-3 pars tensa RPs in adult patients? Currently conservative treatments for this condition has been shown to be ineffective; there is a significant risk of progression to hearing loss or more serious complications in untreated retraction pockets; and the surgical treatments available to us in the UK not only have a number of risks and drawbacks, but also do not aim to treat the underlying cause (Eustachian Tube dysfunction (ETD)).

Interventions

DEVICEBielefeld balloon

Balloon Eustachian tuboplasty = dilatation of the cartilaginous Eustachian tube with a balloon catheter device performed with endoscopic control under general anaesthetic

Sponsors

University Hospital Plymouth NHS Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult patients over 18 years old with grade 2-3 retraction pocket of the tympanic membrane as assessed by study clinician.

Exclusion criteria

* Craniofacial abnormalities (assessed by history and examination) * Cholesteatoma (assessed by history, otoscopy, tympanogram, PTA) * Nasopharyngeal tumours (assessed by flexible nasendoscopy) * Adenoid hypertrophy (assessed by flexible nasendoscopy) * Patulous ET (assessed by history, otoscopy and tympanogram) * Previous middle ear surgery (assessed by history and otoscopy) * Concurrent use of anticoagulant medication

Design outcomes

Primary

MeasureTime frameDescription
Acceptability6 monthsAcceptability of the procedure, which will be assessed with pre- and post-procedure using the the seven-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7).
Patient Focus Group6 monthsThematic analysis of Patient Focus Group discussions. Standardised questions and focus group discussion with patients with (i) un-operated asymptomatic Retraction Pockets (RPs), (ii) un-operated symptomatic RPs, (iii) RPs treated with cartilage tympanoplasty, and (iv) RPs treated with BET. These will qualitatively assess (as appropriate) positive and negative aspects of patient experience, such as living with the RP, the procedure itself, their recovery, any after effects, and participating in the study. Focus groups will consist of 6 patients in each group.
Complications6 monthsAn assessment of the number of complications in the 20 participants undergoing BET will also be performed as a marker of safety of the procedure.

Secondary

MeasureTime frameDescription
Ability to perform ValsalvaAssessed pre-intervention and post-intervention at 2 weeks and 6 months.Ability to perform Valsalva measured as always, sometimes or never. Assessed pre-intervention and post-intervention at 2 weeks and 6.
Demand1 yearDemand assessed by recruitment rate
pure-tone average (PTA) hearing lossAssessed pre-intervention and post-intervention at 2 weeks and 6 months.PTA (air conduction at 0.25, 0.5, 1, 2, 3, 4, 6, 8kHz; bone conduction at 0.5, 1, 2, 3, 4 kHz) with calculation of air bone gap at 0.5, 1, 2, 3 and 4kHz. Assessed pre-intervention and post-intervention at 2 weeks and 6 months
TympanometryAssessed pre-intervention and post-intervention at 2 weeks and 6 months.Tympanometry (peak middle ear pressure and compliance, and Jerger grade (Improved, unchanged, worse)). Assessed pre-intervention and post-intervention at 2 weeks and 6 months.
Cost analysis of treatment1 yearCost analysis of BET vs. cartilage tympanoplasty
Comparison of otoendoscopy imagesAssessed pre-intervention and post-intervention at 2 weeks and 6 months.Comparison of otoendoscopy images by two experienced observers and computer software (ImageJ). Assessed pre-intervention and post-intervention at 2 weeks and 6 months.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026